A Network Flow Approach to Predict Protein Targets and Flavonoid Backbones to Treat Respiratory Syncytial Virus Infection.

Background. Respiratory syncytial virus (RSV) infection is the major cause of respiratory disease in lower respiratory tract in infants and young children. Attempts to develop effective vaccines or pharmacological treatments to inhibit RSV infection without undesired effects on human health have bee...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2015; pp. 1 - 10
Autores principales: Vargas, José Eduardo, Puga, Renato, Poloni, Joice de Faria, Saraiva Macedo Timmers, Luis Fernando, Porto, Barbara Nery, Norberto de Souza, Osmar, Bonatto, Diego, Condessa Pitrez, Paulo Márcio, Tetelbom Stein, Renato
Formato: equations & formulas research tables/charts Journal Article
Publicado: Wiley-Blackwell 3/23/2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109273755&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 109273755
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 3/23/2015
      vid: 2015
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        109273755
        109273755
        109273755
        10.1155/2015/301635
        109273755
      ppf: 1
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: A Network Flow Approach to Predict Protein Targets and Flavonoid Backbones to Treat Respiratory Syncytial Virus Infection.
      aug:
        au:
          Vargas, José Eduardo
          Puga, Renato
          Poloni, Joice de Faria
          Saraiva Macedo Timmers, Luis Fernando
          Porto, Barbara Nery
          Norberto de Souza, Osmar
          Bonatto, Diego
          Condessa Pitrez, Paulo Márcio
          Tetelbom Stein, Renato
        affil: Centro Infant, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Avenue Ipiranga 6681, 90619-900 Porto Alegre, RS, Brazil
      sug:
        subj:
          Flavonoids Therapeutic Use
          Proteins Physiology
          Respiratory Syncytial Virus Infections Therapy
          Thoracic Diseases Diagnosis
          Virus Diseases
          Infant
          Child
          Respiratory Syncytial Virus Infections Prevention and Control
          Gene Expression
          Funding Source
          Infant: 1-23 months
          Child: 6-12 years
      ab: Background. Respiratory syncytial virus (RSV) infection is the major cause of respiratory disease in lower respiratory tract in infants and young children. Attempts to develop effective vaccines or pharmacological treatments to inhibit RSV infection without undesired effects on human health have been unsuccessful. However, RSV infection has been reported to be affected by flavonoids. The mechanisms underlying viral inhibition induced by these compounds are largely unknown, making the development of new drugs difficult. Methods. To understand the mechanisms induced by flavonoids to inhibit RSV infection, a systems pharmacology-based study was performed using microarray data from primary culture of human bronchial cells infected by RSV, together with compound-proteomic interaction data available for Homo sapiens. Results. After an initial evaluation of 26 flavonoids, 5 compounds (resveratrol, quercetin, myricetin, apigenin, and tricetin) were identified through topological analysis of a major chemical-protein (CP) and protein-protein interacting (PPI) network. In a nonclustered form, these flavonoids regulate directly the activity of two protein bottlenecks involved in inflammation and apoptosis. Conclusions. Our findings may potentially help uncovering mechanisms of action of early RSV infection and provide chemical backbones and their protein targets in the difficult quest to develop new effective drugs.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N